These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 924145)
21. [Treatment with antiplatelet drugs. Current status of knowledge]. Dettori AG; Pini M; Quintavalla R Recenti Prog Med; 1979 Sep; 67(3):346-67. PubMed ID: 392656 [No Abstract] [Full Text] [Related]
22. Medical revolution: the prevention and treatment of stroke, 1996. Part 2. Medical prevention of stroke and acute stroke therapy. Kirshner HS Tenn Med; 1996 Nov; 89(11):410-2. PubMed ID: 8942279 [No Abstract] [Full Text] [Related]
23. XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy. Genton E; Barnett HJ; Fields WS; Gent M; Hoak JC Stroke; 1977; 8(1):150-75. PubMed ID: 835152 [TBL] [Abstract][Full Text] [Related]
24. [Platelet antiaggregants and arteriopathies]. Cristol R J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714 [No Abstract] [Full Text] [Related]
25. [Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy]. Verstraete M Recenti Prog Med; 1980 Apr; 68(4):361-81. PubMed ID: 6992244 [No Abstract] [Full Text] [Related]
27. Antithrombotic agents in coronary artery disease. Resnekov L; Chediak J; Hirsh J; Lewis D Chest; 1986 Feb; 89(2 Suppl):54S-67S. PubMed ID: 3510831 [No Abstract] [Full Text] [Related]
28. Pharmacologic approach to ischemic stroke management. Kasuya A; Holm K Nurs Clin North Am; 1986 Jun; 21(2):289-96. PubMed ID: 3635127 [TBL] [Abstract][Full Text] [Related]
29. [Clinical application and evaluation of anti-platelet agents]. Yasunaga K Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628 [No Abstract] [Full Text] [Related]
30. Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents. Joseph R; D'Andrea G; Oster SB; Welch KM Stroke; 1989 Jan; 20(1):38-44. PubMed ID: 2911833 [TBL] [Abstract][Full Text] [Related]
31. Antiplatelet agents: a review. Gantmacher ML J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644 [No Abstract] [Full Text] [Related]
32. [Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone]. Algra A; De Schryver EL; Halkes PH Ned Tijdschr Geneeskd; 2008 May; 152(20):1179; author reply 1180. PubMed ID: 18549147 [No Abstract] [Full Text] [Related]
33. [Present situation of therapy with platelet aggregation inhibitors]. Poliwoda H Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157 [No Abstract] [Full Text] [Related]
34. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention. Polli EE; Cortellaro M Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788 [No Abstract] [Full Text] [Related]
35. [Problems of anticoagulant and thrombolytic therapy in sinus and cerebral vein thromboses]. Friedmann G; Huhn A; Van de Loo J Radiologe; 1971 Nov; 11(11):424-6. PubMed ID: 5136341 [No Abstract] [Full Text] [Related]
37. [Place of antiplatelet agents in the prevention of cerebral ischemic strokes]. Bousser MG Ann Med Interne (Paris); 1983; 134(2):79-83. PubMed ID: 6349464 [No Abstract] [Full Text] [Related]
38. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]
39. [Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"]. Inzitari D; Fratiglioni L; Baldereschi M; Candelise L; Anzalone N; Bonatti ML; Prencipe M; Gandolfo C; Mamoli A; Rasura M Epidemiol Prev; 1990 Jun; 12(43):6-11. PubMed ID: 2149110 [No Abstract] [Full Text] [Related]